Related by context. All words. (Click for frequent words.) 70 generalized tonic clonic seizures 69 divalproex sodium 69 lipid lowering agents 69 certolizumab 69 antiarrhythmic drug 68 IOP lowering 68 polytherapy 68 β blockers 67 salmeterol fluticasone 67 Infusion Reactions Severe 67 antiepileptics 67 flutamide 67 TMP SMX 67 calcineurin inhibitor 67 concomitant medications 66 MIRAPEX 66 ARB telmisartan 66 pyridostigmine 66 TEAEs 66 Lamictal XR 66 antiepileptic drugs AEDs 66 oral anticoagulation 66 haematologic 66 EDSS scores 66 revascularization procedures 66 corticosteroid dose 66 ATACAND 65 elevated LDH 65 INVEGA ® 65 4mg/kg 65 antiepileptic medications 65 ALT flares 65 olanzapine LAI 65 oral olanzapine 65 methotrexate monotherapy 65 fibrinolytic therapy 65 RLAI 65 APTIVUS r 65 Elitek 65 neuroleptics 65 oxcarbazepine 65 generalized seizures 65 thienopyridine 65 CAELYX 65 atorvastatin #mg 65 tolterodine ER 65 severe exacerbations 65 prednisone prednisolone 65 moderately emetogenic 65 oral antidiabetic drugs 65 ACEIs 65 oral corticosteroids 65 anticoagulant warfarin 64 dalteparin 64 GnRH agonists 64 VIIBRYD 64 thiazide diuretic 64 clobazam 64 AGILECT R 64 systemic corticosteroids 64 corticosteroid therapy 64 thrombocytopenic patients 64 typical antipsychotics 64 Zavesca R 64 risperidone Risperdal 64 rufinamide 64 KRAS mutations occur 64 analgesic medications 64 mycophenolate mofetil 64 HbA 1c levels 64 oral prednisolone 64 fluticasone salmeterol 64 adverse cytogenetics 64 antidiabetic medications 64 nicardipine 64 hepatorenal syndrome 64 revascularizations 64 intravitreal injections 64 idraparinux 64 antiemetics 64 relapsed MM 64 systemic corticosteroid 64 laboratory abnormalities 64 renal insufficiency 64 postoperative morbidity 64 ß blockers 63 sotalol 63 SSRI SNRI 63 follicular lymphoma FL 63 anagrelide 63 bezafibrate 63 micafungin 63 #mg/day [001] 63 oral antidiabetic medication 63 chemoradiation therapy 63 moderate renal impairment 63 NATRECOR R 63 LHRH agonists 63 FluCAM arm 63 ICD shocks 63 generalized edema 63 PASI scores 63 inotropes 63 stavudine d4T 63 RISPERDAL ® 63 NNT = 63 tacrolimus ointment 63 hematologic toxicity 63 partial onset seizures 63 adjunctive placebo 63 beta blocker therapy 63 metformin monotherapy 63 dopaminergic therapy 63 anticholinergic medication 63 antiplatelet drugs 63 biologic DMARD 63 recurrent glioblastoma multiforme 63 β blocker 63 pamidronate 63 antiandrogen 63 thrombolytic agents 63 antihypertensive agents 63 quetiapine Seroquel 63 milrinone 63 EFFEXOR XR 63 oral antidiabetic agents 63 acarbose 63 placebo dexamethasone 63 DMARDS 63 AGHD 63 antithrombotics 63 AVELOX 63 postintervention 63 eosinophilic asthma 63 LNG IUS 63 GnRH agonist 63 postoperative AF 63 lamotrigine 63 TNF alpha inhibitor 63 tipranavir ritonavir 63 calcineurin inhibitors 63 antiandrogens 63 venlafaxine Effexor 63 peginterferon alfa 63 alpha interferons 63 cranial irradiation 63 DMARDs 63 MMSE score 63 #mg doses [002] 63 tolterodine 63 Helicobacter pylori eradication 63 clomipramine 63 unfavorable cytogenetics 63 angiotensin converting enzyme inhibitors 63 pentoxifylline 63 ARIXTRA 63 unresectable HCC 62 non selective NSAIDs 62 NPH insulin 62 levetiracetam 62 pulmonary dysfunction 62 timepoints 62 5-FU/LV 62 achieved ACR# 62 tamoxifen Nolvadex ® 62 non metastatic osteosarcoma 62 anticholinergic agents 62 doxazosin 62 lacosamide 62 COPD exacerbation 62 comorbid diagnoses 62 LMWH 62 onset seizures 62 LOVENOX R 62 interferon alfa 2b 62 divalproex 62 CsA 62 unfractionated heparin UFH 62 ritonavir boosted lopinavir 62 lenalidomide dexamethasone 62 TNF antagonist 62 HIV HCV coinfected 62 oral corticosteroid 62 comorbid depression 62 TNF inhibitor 62 solifenacin 62 Flu Cy 62 FAMPYRA 62 tipranavir r 62 recurrent tonsillitis 62 upper gastrointestinal bleeding 62 reinfarction 62 glycated hemoglobin levels 62 mcg QD 62 hemorrhagic cystitis 62 mycophenolate mofetil MMF 62 ziprasidone 62 antihypertensive therapy 62 docetaxel prednisone 62 anemia neutropenia 62 postoperative chemotherapy 62 Thal Dex 62 symptomatic paroxysmal AF 62 mycophenolic acid 62 FROVA 62 nadolol 62 paliperidone ER 62 fluoxetine paroxetine 62 EXJADE 62 alteplase 62 diarrhea predominant IBS 62 CIMZIA ™ 62 Postoperative complications 62 neuroleptic 62 neutropaenia 62 events TEAEs 62 glycoprotein IIb IIIa inhibitors 62 metastatic carcinoid tumors 62 rFVIIa 62 symptomatic hyponatremia 62 rebleeding 62 antiepileptic drug 62 antiepileptic drugs 62 Adjunctive 62 olmesartan 62 candidemia 62 intravenous bisphosphonates 62 CIMZIA TM certolizumab pegol 62 aspirin clopidogrel 62 intravenous diuretics 62 eculizumab therapy 62 labetalol 62 autologous SCT 62 postoperative complication 62 androgen deprivation 62 primidone 62 poor metabolizers 62 tranylcypromine 62 hypokalemia 62 bolus dose 62 comorbid illnesses 61 tapentadol ER 61 lipid lowering medication 61 T2DM 61 antiarrhythmic drugs 61 primary aldosteronism 61 antimuscarinic 61 arterial thromboembolic events 61 levodopa therapy 61 desmopressin 61 neuroleptic drugs 61 conventional angiography 61 ARCOXIA 61 long acting bronchodilator 61 antithrombotic therapy 61 NSTEMI 61 tegaserod 61 transaminase elevations 61 mild renal insufficiency 61 insulin glulisine 61 atrioventricular block 61 adverse reactions incidence 61 dosage regimens 61 pegaptanib 61 acromegalic patients 61 amisulpride 61 ACTEMRA TM 61 androgen suppression 61 colorectal liver metastases 61 octreotide LAR 61 lung resection 61 oral hypoglycemic agents 61 PEGINTRON TM 61 interferon ribavirin 61 adjunctive ABILIFY 61 desvenlafaxine succinate 61 somatostatin analogues 61 inotropic therapy 61 SPRYCEL ® 61 psychiatric comorbidity 61 tamsulosin 61 mg kg dose 61 patients undergoing CABG 61 leukotriene receptor antagonists 61 PSVT 61 prazosin 61 postoperative infections 61 newer atypical antipsychotics 61 5-fluorouracil/leucovorin 61 antiplatelet medication 61 CTEPH 61 adrenal insufficiency 61 neutropenic fever 61 vWD 61 Adjuvant chemotherapy 61 SCIg 61 abacavir lamivudine 61 oral hypoglycemic agent 61 caspofungin 61 CHOP chemotherapy 61 NATRECOR ® 61 conventional antipsychotics 61 aripiprazole Abilify 61 malignant neoplasms 61 comorbid psychiatric 61 ZYVOX 61 Natalizumab 61 darunavir r 61 Keppra R 61 antiarrhythmic medications 61 peginterferon alfa 2b 61 extrapyramidal symptoms 61 virologic breakthrough 61 oxycodone CR 61 coronary revascularization 61 immunosuppressive medications 61 DOXIL 61 cilostazol 61 BYSTOLIC 61 GP IIb IIIa inhibitor 61 nondiabetic patients 61 aripiprazole 61 Abilify aripiprazole 61 virological failure 61 pimecrolimus cream 61 RezularTM 61 hypomagnesemia 61 anticholinergic medications 61 reintubation 61 mycophenolate 61 droperidol 61 percutaneous drainage 61 enalapril 61 titrated glipizide 61 ORENCIA ® 61 placebo intravenously 61 hydroxyurea therapy 61 LPV r 61 PSA nadir 61 ritonavir boosted protease inhibitor 61 protease inhibitor PI 61 antihyperglycemic 61 HBeAg negative patients 61 severe renal impairment 61 acitretin 61 intravenous cyclophosphamide 61 antidiabetes 61 antithrombotic agent 61 aldosterone antagonists 61 REMICADE ® 61 mesalamine granules 61 neuropsychiatric symptoms 61 paclitaxel eluting stents 61 attain statistical significance 61 adriamycin 61 myopathy rhabdomyolysis 61 rosuvastatin #mg 61 perioperatively 61 renal impairment 61 levosimendan 61 angiographic outcomes 61 metformin sulfonylurea 61 carotid stenosis 61 definite stent thrombosis 61 immune thrombocytopenic purpura ITP 61 venous thromboembolic disease 61 NIHSS score 61 IBS C 61 Vimpat R 61 unstable angina pectoris 61 thromboembolic complications 61 psychiatric comorbidities 61 thromboprophylaxis 61 HIV lipodystrophy 61 methotrexate therapy 61 intracranial hemorrhage ICH 61 insulin detemir 61 VaD 61 carbidopa levodopa 61 hepatic metastases 61 sensory neuropathy 61 LATUDA 60 VFEND 60 MEVACOR 60 preoperative chemotherapy 60 perioperative mortality 60 intravenous vancomycin 60 antimicrobial prophylaxis 60 PREMPRO 60 SSRI citalopram 60 MoxDuo TM IR 60 adjuvant therapies 60 tocilizumab 60 cinacalcet 60 CANCIDAS 60 detrusor overactivity 60 cerebrovascular events 60 renoprotective 60 OADs 60 methimazole 60 non aspirin NSAIDs 60 oral diclofenac 60 dopamine partial agonist 60 Atypical antipsychotics 60 oral anticoagulant therapy 60 ticlopidine 60 AZT zidovudine Retrovir 60 glatiramer acetate 60 symptomatic VTE 60 benazepril 60 heparin induced thrombocytopenia 60 Ventavis ® 60 symptomatic carotid stenosis 60 oral antidiabetes drugs 60 phenytoin 60 tenofovir emtricitabine 60 PREZISTA r 60 virological response 60 tenecteplase 60 rizatriptan 60 tirofiban 60 HCV RESPOND 2 60 proliferative diabetic retinopathy 60 ribavirin therapy 60 concurrent chemoradiation 60 highly emetogenic 60 anticonvulsant medications 60 antiplatelet medications 60 immunosuppressive agents 60 left ventricular dysfunction 60 amphotericin B 60 antihypertensive medication 60 FASLODEX 60 QTc prolongation 60 hypercholesterolaemia 60 oral allopurinol 60 KETEK 60 anthracycline taxane 60 efalizumab 60 CONCERTA 60 atypical antipsychotic medications 60 partial remissions 60 overactive bladder syndrome 60 CONCERTA ® 60 inhaled bronchodilators 60 dexmedetomidine 60 mg clopidogrel 60 FOLFOX4 60 baseline HbA1c 60 paresthesias 60 KAPIDEX 60 paroxetine Paxil 60 oral hypoglycemic 60 Navelbine ® 60 elevated IOP 60 virologically 60 DPNP 60 dacarbazine chemotherapy 60 binary restenosis 60 rimonabant #mg 60 irbesartan 60 ano genital warts 60 buprenorphine implants 60 reoperations 60 COMBIVIR 60 FOSRENOL ® 60 gadobutrol 60 asthma exacerbation 60 DMARD therapy 60 anti arrhythmic drugs 60 prodromal symptoms 60 AGILECT ® 60 trials RCTs 60 anticoagulant medications 60 lamivudine monotherapy 60 chest radiographs 60 receiving VICTRELIS 60 bowel resection 60 Potiga 60 GLIADEL R Wafer 60 periprocedural 60 angiotensin converting enzyme inhibitor 60 liver metastasis 60 AMEVIVE 60 MULTAQ 60 nonadherent 60 radiotherapy RT 60 hematological adverse 60 PegIntron 60 carcinoids 60 myelosuppressive 60 antihypertensive medications 60 canakinumab 60 nadroparin 60 Serious adverse reactions 60 inhaled anticholinergics 60 tolvaptan 60 chlorthalidone 60 oral levofloxacin 60 mcg BID 60 debulking surgery 60 standard chemotherapy regimens 60 neutropenic patients 60 atherosclerotic renal artery stenosis 60 euthyroid 60 Losartan 60 H2 receptor antagonists 60 Doxil ® 60 oral vancomycin 60 LTRA 60 PONV 60 % CI #.#-#.# [008] 60 immunosuppressive regimen 60 tricyclic antidepressant 60 skeletal metastases 60 nasal polyposis 60 curative resection 60 de novo AML 60 induce orthostatic hypotension 60 COREG 60 AChE inhibitors 60 prescribed opioids 60 Pegasys peginterferon alfa 2a 60 STELARA ™ 60 unfractionated heparin 60 inhaled budesonide 60 endometrial hyperplasia 60 Peg IFN 60 BENICAR HCT 60 salmeterol fluticasone propionate 60 Capecitabine 60 CYPHER Stent 60 external beam radiotherapy 60 TPV r 60 Heavy menstrual bleeding 60 gemifloxacin 60 clinically meaningful improvements 60 MADRS score 60 ARCALYST ® 60 TAVR 60 adenomatous 60 p = #.# [003] 60 pericardial effusion 60 hypoglycemic events 60 stable angina 60 pooled comparator 60 GH deficiency 60 mg administered orally 60 prior chemotherapy regimens 60 Azathioprine 60 neutropenia dehydration dyspnea 60 Lucentis monotherapy 60 Nesiritide 60 percutaneous vertebroplasty 60 quetiapine 60 CorVue TM 60 immunosuppressives 60 ACTOplus met XR 60 clodronate 60 cholinesterase inhibitor 60 INVEGA ™ 60 INVEGA SUSTENNA 60 Quetiapine 60 glycoprotein IIb IIIa inhibitor 60 aldosterone antagonist 60 histologic subtype 60 urodynamic parameters 60 FOLFIRI 60 INVEGA 60 anticonvulsant drugs 60 dacarbazine 60 severe hypoglycaemia 60 saline placebo 60 squamous histology 60 prednisone steroid 60 BoNTA 59 antirheumatic 59 FOLFIRI alone 59 lipid lowering medications 59 hepatic encephalopathy HE 59 bronchogenic carcinoma 59 subcutaneous dosing 59 systemic hypotension 59 genotypic resistance 59 underwent CABG 59 fluvoxamine Luvox 59 hematologic adverse 59 #mg dose [003] 59 biliary tract cancer 59 montelukast 59 ritonavir boosted 59 hematologic abnormalities 59 inhaled glucocorticoids 59 adrenal suppression 59 ULORIC 59 RAPTIVA 59 HbA1c levels 59 folinic acid 59 syncopal episodes 59 MIRAPEX ER 59 NUCYNTA R 59 underwent surgical resection 59 VT VF 59 pyrexia mucositis sepsis febrile 59 comorbid conditions 59 leukopenia 59 ejection fractions 59 RAS blockers 59 tricyclic antidepressants 59 glitazone 59 otamixaban 59 goserelin 59 VTEs 59 syncope fainting 59 thiazides 59 recurrent VTE 59 malignant neoplasm 59 hypertensives 59 Carotid endarterectomy 59 MAO inhibitors 59 glatiramer 59 metastatic malignant 59 nonoperative treatment 59 oral antidiabetes 59 macroalbuminuria 59 PREZISTA r arm 59 atypical antipsychotic medication 59 immunomodulatory therapy 59 antihypertensive drugs 59 postprocedure 59 LYSTEDA 59 acute mania 59 weekly subcutaneous injections 59 dyslipidaemia 59 intravesical therapy 59 colorectal adenoma 59 AZILECT 59 dosing frequency 59 pegylated interferon alfa 59 GP IIb IIIa inhibitors 59 ONTAK 59 Navelbine 59 lipid lowering drugs 59 hepatic insufficiency 59 pacemaker implantation 59 mcg albinterferon alfa 2b 59 agomelatine 59 hyperprolactinemia 59 narcotic analgesics 59 pegylated alpha interferon 59 TURBT 59 danazol 59 chemotherapeutic regimens 59 HAART regimen 59 KRAS mutant tumors 59 low dose Iluvien 59 nephrotoxicity 59 overactive bladder symptoms 59 comparator arm 59 electrolyte abnormalities 59 acupuncture sham acupuncture 59 receiving ISENTRESS 59 inotropic 59 episodic migraine 59 Exclusion criteria 59 haloperidol Haldol 59 sertraline Zoloft 59 treprostinil 59 alpha blocker 59 akinesia 59 XELOX 59 INFERGEN 59 PPAR gamma agonists 59 glitazones 59 acute coronary syndromes ACS 59 BANZEL 59 hallucinations dyskinesia 59 QVAR R 59 REYATAZ r arm 59 tumor histology 59 smoldering multiple myeloma 59 amoxicillin clavulanate 59 RoACTEMRA 59 chemoradiotherapy 59 acting injectable formulation 59 thyrotoxicosis 59 monotherapy 59 anticlotting drugs 59 NEUPOGEN 59 Targretin capsules 59 HBeAg seroconversion 59 oral rivaroxaban 59 chemoembolization 59 Seroquel quetiapine fumarate 59 incidence ≥ 59 carotid revascularization 59 hypochondriasis 59 undetectable HBV DNA 59 Treatment discontinuations due 59 fibrinolysis 59 ancrod 59 L dopa 59 pancreatic insufficiency 59 p = NS 59 UA NSTEMI 59 venous thromboembolic events 59 ddI 59 Velcade bortezomib 59 neurologic sequelae 59 nonvertebral fracture 59 NYHA functional class 59 Peripheral edema 59 glargine 59 guanfacine extended release 59 Decitabine 59 8mg/kg 59 xanthine oxidase inhibitor 59 venlafaxine XR 59 recurrent DVT 59 TMC# r 59 decompensated cirrhosis 59 Lipitor #mg 59 hemodialysis patients 59 aromatase inhibitor therapy 59 tuberous sclerosis TS 59 lopinavir r arm 59 serotonin reuptake inhibitors 59 #mg/day [002] 59 serum urate 59 TNF inhibitors 59 chronic LBP 59 coxib 59 fluvastatin 59 VTE prophylaxis 59 LV dysfunction 59 achieved sustained virological 59 non splenectomized 59 overt nephropathy 59 ziconotide 59 electrical cardioversion 59 antibiotic prophylaxis 59 Raptiva ® 59 invasive candidiasis 59 nonfatal MI 59 Anticonvulsants 59 abacavir Ziagen 59 paroxysmal AF 59 inhaled treprostinil 59 conjugated estrogens 59 chronic idiopathic thrombocytopenic purpura 59 nonpsychotic 59 oral naltrexone 59 PULMICORT RESPULES 59 Veramyst 59 mRCC 59 ALND 59 atrophic gastritis 59 Lantus insulin 59 thrombotic complications 59 Copegus ribavirin 59 TEMODAL 59 Zavesca ® 59 inhaled corticosteroid therapy 59 symptomatic intracranial 59 symptom exacerbation 59 endoscopic remission 59 FIRMAGON 59 nephrotoxic 59 peripheral sensory neuropathy 59 achieved CCyR 59 radioiodine therapy 59 clopidogrel Plavix 59 Hycamtin ® 59 APTIVUS R 59 reflux symptoms 59 achieve sustained virologic 59 decompensated heart failure 59 ventricular fibrillation VF 59 newer antipsychotics 59 prognostic variables 59 oral prednisone 59 adalimumab Humira 59 primary hypercholesterolemia 59 thromboembolic 59 bleeding pallor 59 discontinuations 59 Brinavess 59 gastrointestinal toxicity 59 KRAS status 59 uridine triacetate 59 doxorubicin HCl liposome injection 59 rt PA 59 galantamine 59 metastatic GIST 59 intravitreal triamcinolone 59 hepatic enzymes 59 isoproterenol 59 hyperalgesia 59 constipation nausea 59 HPA axis suppression 59 acetazolamide 59 receiving highly emetogenic 59 metastatic lung cancer 59 serum calcium levels 59 evaluable subjects 59 nonvertebral fractures 59 imiquimod cream 59 cabergoline 59 ribavirin RBV 59 inhaled corticosteroids ICS 59 EDSS score 59 resectable 59 adalimumab 59 Desferal 58 cidofovir 58 serum phosphate levels 58 quinidine 58 receiving XGEVA 58 ischemic complications 58 depressive symptomatology 58 non hematological toxicities 58 macrolide antibiotic 58 thrombocytosis 58 renal dysfunction 58 TORISEL 58 ritonavir boosted atazanavir 58 SUSTIVA 58 valsartan amlodipine 58 lenalidomide Revlimid R 58 MACCE 58 atazanavir ritonavir 58 voriconazole 58 rhinoconjunctivitis 58 advanced adenomas 58 BeneFIX 58 NNRTI resistance 58 noncardiovascular mortality 58 fistula closure 58 Fludarabine 58 acute respiratory tract infections 58 Mitoxantrone 58 XOPENEX Inhalation Solution 58 RBC transfusions 58 taxotere 58 relapsing remitting MS RRMS 58 pharmacologic therapy 58 salmeterol HFA MDI 58 complete cytogenetic response 58 ventricular tachycardia VT 58 guideline concordant 58 phenelzine 58 symptomatic BPH 58 MoxDuo IR 58 radical nephrectomy 58 ropivacaine 58 dyspnoea 58 hypoglycemic episodes 58 abatacept 58 nitrofurantoin 58 eplerenone 58 long acting bronchodilators 58 NIHSS 58 postinjury 58 thalidomide Thalomid 58 ARIMIDEX 58 simvastatin ezetimibe 58 anticoagulation therapy 58 invasive fungal infection 58 loop diuretics 58 DMARD 58 low dose cytarabine 58 imipenem 58 neurologic complications 58 Zevalin consolidation 58 nonischemic 58 somatostatin analogs 58 CIMZIA TM 58 Discontinuations 58 mcg doses 58 lymphocytosis 58 mometasone furoate 58 Lofexidine 58 Operative mortality 58 invasive aspergillosis 58 Certolizumab pegol 58 Retreatment 58 adjunctively 58 constipation predominant IBS 58 interferon gamma 1b 58 aromatase inhibitor AI 58 Sandostatin 58 flecainide 58 hepatic failure 58 ACTOplus met 58 Ramipril 58 refractory epilepsy 58 Pemetrexed 58 rotigotine transdermal patch 58 juvenile idiopathic arthritis JIA 58 proctitis 58 CLL SLL 58 azacitidine 58 artery stenosis 58 aromatase inhibitors AIs 58 morphometric vertebral fractures 58 infliximab monotherapy 58 mania hypomania 58 immunomodulatory therapies 58 pharmacologic treatments 58 recurrent ischemia 58 SJIA 58 Kepivance 58 opioid dependent 58 multivessel disease 58 retinal vein occlusion 58 metastatic malignant melanoma 58 peginterferon 58 antibiotic regimens 58 NMDA antagonists 58 paricalcitol 58 steroid dexamethasone 58 diabetic gastroparesis 58 HeFH 58 mL/min/#.# m 2 58 overlapping toxicities 58 olanzapine quetiapine 58 paliperidone palmitate 58 deep venous thromboses 58 ZOLINZA 58 CPAP adherence 58 teriflunomide 58 elevated ALT 58 renal scarring 58 beta interferons 58 terazosin 58 ximelagatran 58 MYCAMINE 58 myelodysplastic myeloproliferative diseases 58 anastomotic leak 58 VAPRISOL 58 saline infusion 58 dobutamine 58 Personal CGM 58 anthracycline chemotherapy 58 ORENCIA R 58 anakinra 58 rhGH 58 dose titration 58 vecuronium 58 mitoxantrone 58 MMSE scores 58 uric acid lowering 58 somatostatin analog 58 HER2 overexpression 58 generalized anxiety disorder GAD 58 titration phase 58 CCyR 58 argatroban 58 hematologic parameters 58 #mg ATC 58 headache abdominal pain 58 coinfected patients 58 androgen ablation 58 immunosuppressive therapies 58 TDF FTC 58 Aloxi injection 58 elevated transaminases 58 memantine Namenda 58 anticholinergics 58 #mg QD [001] 58 Febrile neutropenia 58 Intravenous immunoglobulin 58 neurologic symptoms 58 mg Pycnogenol 58 dysfunctional voiding 58 hypotensive 58 #mg BID [001] 58 Dacogen decitabine 58 PRISTIQ 58 AZILECT R 58 MAS XR 58 Topical corticosteroids 58 Keppra XR 58 antiarrhythmic 58 interferon therapy 58 boosted protease inhibitor 58 erlotinib Tarceva 58 hip resurfacing arthroplasty 58 docetaxel chemotherapy 58 antithrombotic 58 lipid lowering therapy 58 potentially hepatotoxic 58 APTIVUS ritonavir 58 galiximab 58 ofpatients 58 Oral corticosteroids 58 resynchronization therapy 58 Plaquenil 58 Fludara